SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
HAASER CHARLES B
(Last) (First) (Middle)
C/O ABIOMED, INC.
22 CHERRY HILL DRIVE
(Street)
DANVERS MA 01923
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ABIOMED INC [ ABMD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Principal Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/08/2006
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $.01 par value 2,379 D
Common Stock, $.01 par value 02/08/2006 M 5,000 A $4.844 7,379 D
Common Stock, $.01 par value 02/08/2006 S 5,000 D $10.25 2,379 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy)(3) $4.844 02/08/2006 M 5,000 11/02/2000(1) 11/02/2008 Common Stock 5,000 $4.844 0 D
Stock Option (right to buy)(3) $6.688 07/01/2001(2) 07/01/2009 Common Stock 1,400 1,400 D
Stock Option (right to buy)(4) $15.563 06/28/2002(6) 06/28/2010 Common Stock 10,000 10,000 D
Stock Option (right to buy)(5) $18.4 08/08/2003(7) 08/08/2011 Common Stock 5,000 5,000 D
Stock Option (right to buy)(5) $6.75 06/25/2004(8) 06/25/2012 Common Stock 5,000 5,000 D
Stock Option (right to buy)(4) $5.11 06/25/2005(9) 06/25/2013 Common Stock 5,000 5,000 D
Stock Option (right to buy)(5) $12.3 07/01/2005(10) 07/01/2014 Common Stock 15,000 15,000 D
Stock Option (right to buy)(5) $10.8 03/01/2006(10) 03/01/2015 Common Stock 12,500 $12,500 D
Stock Option (right to buy)(5) $9.36 06/08/2006(10) 06/08/2015 Common Stock 20,000 20,000 D
Explanation of Responses:
1. Original option grant becomes exercisable in annual 25% installments commencing on the date shown.
2. Thirty percent of the original option grant became exercisable on 7/1/01 and were subsequently exercised. Another 30 percent became exercisable on 7/1/02 and an additional 40 percent will become exercisable on 7/1/03.
3. Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 1992 Combination Stock Option Plan.
4. Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 1998 Equity Incentive Plan.
5. Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan.
6. Thirty percent of this option will become exercisable on each of 6/28/02 and 6/28/03 and an additional 40 percent will become exercisable on 6/28/04.
7. Thirty percent of this option will become exercisable on each of 8/8/03 and 8/8/04 and an additional 40 percent will become exercisable on 8/8/05.
8. Thirty percent of this option will become exercisable on each of 6/25/04 and 6/25/05 and an additional 40 percent will become exercisable on 6/25/06.
9. Thirty percent of this option will become exercisable on each of 6/25/05 and 6/25/06 and an additional 40 percent will become exercisable on 6/25/07.
10. These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
/s/ Charles B. Haaser 02/10/2006
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.